Osimertinib as first-line treatment for recurrent lung cancer patients with EGFR mutation
@article{JTD79437, author = {Atsushi Osoegawa and Takashi Karashima and Yohei Takumi and Takahiro Sato and Miyuki Abe and Takafumi Hashimoto and Kenji Sugio}, title = {Osimertinib as first-line treatment for recurrent lung cancer patients with EGFR mutation}, journal = {Journal of Thoracic Disease}, volume = {15}, number = {10}, year = {2023}, keywords = {}, abstract = {}, issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/79437} }